NASDAQ:LXRX
Lexicon Pharmaceuticals, Inc.
- Stock
Last Close
1.43
06/11 22:31
Market Cap
589.23M
Beta: 1.33
Volume Today
4.08M
Avg: 593.73K
PE Ratio
−3.21
PFCF: −3.75
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -100.29M - | -4.68M 95.33% | -141.43M 2,920.70% | -129.05M 8.75% | -120.55M 6.59% | 130.13M 207.95% | -58.57M 145.01% | -87.76M 49.82% | -101.94M 16.16% | -177.12M 73.74% | |
depreciation and amortization | 1.93M - | 727K 62.29% | 2.06M 182.81% | 3.40M 65.32% | 3.68M 8.36% | 3.65M 0.79% | 2.93M 19.70% | 292K 90.05% | 427K 46.23% | 554K 29.74% | |
deferred income tax | -70K - | 3.55M 5,171.43% | 16K 99.55% | -12.66M 79,231.25% | -6.01M - | -110K 98.17% | 49K 144.55% | -5.09M - | |||
stock based compensation | 7.08M - | 6.84M 3.36% | 7.45M 8.90% | 9.47M 27.11% | 11.70M 23.48% | 14.22M 21.56% | 13.27M 6.64% | 10.58M 20.32% | 11.52M 8.92% | 14.34M 24.48% | |
change in working capital | 2.29M - | 171.89M 7,399.61% | -43.55M 125.33% | -59.26M 36.08% | -44.77M 24.44% | -58.29M 30.18% | 31.08M 153.32% | -10.23M 132.92% | 402K 103.93% | 5.09M 1,166.42% | |
accounts receivables | 457K - | 124K 72.87% | -4.08M 3,390.32% | 166K 104.07% | -1.10M 762.05% | -50.61M 4,504.91% | 53.23M 205.18% | 381K 99.28% | -14K 103.67% | -982K 6,914.29% | |
inventory | -128K - | -5.79M 4,422.66% | 6.23M 207.57% | -1.95M 131.28% | -2.73M 40.25% | 437K 116.00% | 345K 21.05% | -381K - | |||
accounts payables | 1.27M - | 6.20M 389.97% | 27.65M 345.75% | -7.17M 125.94% | -18.86M 162.93% | 20.10M 206.58% | -20.97M 204.34% | -14.16M 32.48% | 76K 100.54% | 6.45M 8,392.11% | |
other working capital | 697K - | 171.35M 24,484.36% | -73.34M 142.80% | -50.30M 31.41% | -22.09M 56.09% | -28.21M 27.74% | -1.52M 94.60% | 3.55M 332.68% | 340K 90.41% | -5.09M 1,597.35% | |
other non cash items | 13.44M - | 6.45M 52.03% | -176K 102.73% | 2.70M 1,635.80% | 1.34M 50.57% | 30.10M 2,153.22% | -131.57M 537.07% | 54K 100.04% | 744K 1,277.78% | -4.76M 740.19% | |
net cash provided by operating activities | -75.62M - | 184.78M 344.34% | -175.63M 195.05% | -185.39M 5.56% | -148.61M 19.84% | 113.81M 176.58% | -142.97M 225.62% | -87.02M 39.14% | -88.85M 2.11% | -161.90M 82.21% | |
investments in property plant and equipment | -80K - | -910K 1,037.50% | -231K 74.62% | -228K 1.30% | -95K 58.33% | -70K 26.32% | -87K 24.29% | -1.22M 1,303.45% | -1.33M 8.60% | -470K 64.56% | |
acquisitions net | 155.78M - | 11.01M 92.93% | -3.33M 130.25% | 69.75M 2,194.03% | |||||||
purchases of investments | -221.95M - | -326.45M 47.08% | -425.67M 30.40% | -267.87M 37.07% | -119.99M 55.21% | -322.38M 168.68% | -58.55M 81.84% | -34.26M 41.49% | -133.95M 290.97% | -223.34M 66.74% | |
sales maturities of investments | 111.44M - | 210M 88.44% | 444.16M 111.50% | 318.62M 28.26% | 289.66M 9.09% | 166.60M 42.48% | 268M 60.86% | 37.59M 85.97% | 64.20M 70.77% | 173.87M 170.84% | |
other investing activites | 2.17M - | 335K 84.56% | -155.78M - | 160.38M 202.95% | 3.33M 97.92% | -69.75M 2,194.03% | |||||
net cash used for investing activites | -108.42M - | -117.02M 7.93% | 18.25M 115.60% | 50.52M 176.80% | 169.58M 235.65% | -155.85M 191.91% | 380.76M 344.30% | 2.11M 99.45% | -71.08M 3,468.63% | -49.94M 29.73% | |
debt repayment | -1.71M - | -1.86M 8.71% | -2.02M 8.45% | -2.28M 13.10% | -14.53M 537.41% | -1.28M 91.16% | -216.58M 16,754.47% | -11.70M 94.60% | -48.87M 317.68% | -49.96M 2.24% | |
common stock issued | 202.27M - | 114K 99.94% | 3.62M 3,078.95% | 7.99M 120.39% | 732K 90.84% | 69.97M - | 37.08M 47.00% | 94.20M 154.03% | 138.82M 47.36% | ||
common stock repurchased | -887K - | -357K 59.75% | -621K 73.95% | -1.68M 170.37% | -972K 42.11% | -941K 3.19% | -1.03M 9.03% | -2.67M 160.72% | -864K 67.70% | -824K 4.63% | |
dividends paid | -2.02M - | -216.58M - | -11.70M 94.60% | ||||||||
other financing activites | 84.14M - | 70K 99.92% | 2.02M 2,780% | 145.91M 7,137.35% | 12.53M 91.41% | -2.23M 117.77% | 216.58M 9,829.56% | 11.70M 94.60% | 97.74M 735.35% | 99.92M 2.24% | |
net cash used provided by financing activities | 283.81M - | -2.03M 100.72% | 987K 148.57% | 149.93M 15,090.78% | -2.24M 101.50% | -2.23M 0.80% | -147.64M 6,532.35% | 22.71M 115.38% | 142.21M 526.22% | 187.96M 32.17% | |
effect of forex changes on cash | |||||||||||
net change in cash | 99.77M - | 65.72M 34.12% | -156.39M 337.95% | 15.06M 109.63% | 18.73M 24.33% | -44.27M 336.44% | 90.15M 303.62% | -62.20M 168.99% | -17.72M 71.51% | -23.88M 34.76% | |
cash at beginning of period | 37.50M - | 137.27M 266.05% | 202.99M 47.88% | 46.60M 77.04% | 61.66M 32.32% | 80.39M 30.37% | 36.11M 55.08% | 126.26M 249.64% | 64.06M 49.26% | 46.34M 27.66% | |
cash at end of period | 137.27M - | 202.99M 47.88% | 46.60M 77.04% | 61.66M 32.32% | 80.39M 30.37% | 36.11M 55.08% | 126.26M 249.64% | 64.06M 49.26% | 46.34M 27.66% | 22.46M 51.53% | |
operating cash flow | -75.62M - | 184.78M 344.34% | -175.63M 195.05% | -185.39M 5.56% | -148.61M 19.84% | 113.81M 176.58% | -142.97M 225.62% | -87.02M 39.14% | -88.85M 2.11% | -161.90M 82.21% | |
capital expenditure | -80K - | -910K 1,037.50% | -231K 74.62% | -228K 1.30% | -95K 58.33% | -70K 26.32% | -87K 24.29% | -1.22M 1,303.45% | -1.33M 8.60% | -470K 64.56% | |
free cash flow | -75.70M - | 183.87M 342.88% | -175.86M 195.65% | -185.62M 5.55% | -148.70M 19.89% | 113.74M 176.49% | -143.06M 225.78% | -88.24M 38.32% | -90.18M 2.20% | -162.37M 80.05% |
All numbers in USD (except ratios and percentages)